Composition of Certain Financial Statement Captions (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Accounts receivable, net
Accounts receivable	$ 22,642		$ 21,652
Less: allowance for doubtful accounts	(1,432)		(1,885)
Accounts receivable, net	21,210	[1]	19,767	[1]
Inventories, net
Finished products	11,355		13,374
Work in-process	1,040		1,350
Raw materials	4,859		4,132
Less: inventory reserve	(592)		(777)
Inventory, net	16,662	[1]	18,079	[1]
Prepaid expense and other assets:
Prepaid supplies	1,626		945
Prepaid insurance	944		892
Pharmsynthez notes receivable	0		6,151
Other receivables	565		1,985
Taxes recoverable	1,292		3,458
Other	2,591		5,653
Prepaid expenses and other current assets	7,018	[1]	19,084	[1]
Intangible assets, net:
Less: accumulated amortization	(31,527)		(24,403)
Intangible assets, net	65,553	[1]	74,533	[1]
Accrued expenses:
Taxes payable	325		702
Deferred revenue	5,147		7,639
Clinical trials	5,524		3,342
Professional fees	766		402
Employee benefits	5,614		4,399
Deferred acquisition payments, net of discount	0		5,465
Contingent consideration	25,857		28,047
Other	12,321		15,878
Accrued expenses	55,554	[1]	65,874	[1]
Other long-term liabilities:
Mortgages and other debts payable	2,627		3,270
Deferred tax liabilities	164,512		166,435
Other, including deferred revenue	3,658		1,509
Other long-term liabilities	216,174	[1]	214,775	[1]
OPKO Renal
Other long-term liabilities:
Contingent consideration	35,425		34,401
OPKO Health Europe
Other long-term liabilities:
Contingent consideration	292		504
OPKO Diagnostics
Other long-term liabilities:
Contingent consideration	9,237		8,340
CURNA
Other long-term liabilities:
Contingent consideration	423		316
Technologies
Intangible assets, net:
Intangible assets	52,694		51,660
Customer relationships
Intangible assets, net:
Intangible assets	22,153		22,725
Product registrations
Intangible assets, net:
Intangible assets	8,941		9,692
Trade names
Intangible assets, net:
Intangible assets	3,509		3,669
Covenants not to compete
Intangible assets, net:
Intangible assets	8,652		8,671
Other
Intangible assets, net:
Intangible assets	$ 1,131		$ 2,519

[1] As of September 30, 2014 and December 31, 2013, total assets include $7.4 million and $6.7 million, respectively, and total liabilities include $13.1 million and $10.4 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.